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Flow of cerebrospinal ﬂuid is driven by arterial
pulsations and is reduced in hypertension
Humberto Mestre 1,2, Jeffrey Tithof 3, Ting Du1,4, Wei Song1, Weiguo Peng1,5, Amanda M. Sweeney1,
Genaro Olveda1, John H. Thomas3, Maiken Nedergaard1,5 & Douglas H. Kelley 3
Flow of cerebrospinal ﬂuid (CSF) through perivascular spaces (PVSs) in the brain is important
for clearance of metabolic waste. Arterial pulsations are thought to drive ﬂow, but this has
never been quantitatively shown. We used particle tracking to quantify CSF ﬂow velocities in
PVSs of live mice. CSF ﬂow is pulsatile and driven primarily by the cardiac cycle. The speed of
the arterial wall matches that of the CSF, suggesting arterial wall motion is the principal
driving mechanism, via a process known as perivascular pumping. Increasing blood pressure
leaves the artery diameter unchanged but changes the pulsations of the arterial wall,
increasing backﬂow and thereby reducing net ﬂow in the PVS. Perfusion-ﬁxation alters the
normal ﬂow direction and causes a 10-fold reduction in PVS size. We conclude that particle
tracking velocimetry enables the study of CSF ﬂow in unprecedented detail and that studying
the PVS in vivo avoids ﬁxation artifacts.
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Cerebrospinal ﬂuid (CSF) aids in the removal of metabolicwaste from the brain1. The exact anatomical pathways andmechanisms underlying how solutes in the interstitial ﬂuid
(ISF) are transported towards CSF remain unclear2. Historically,
it has been thought that solutes exit the brain along a network of
perivascular spaces (PVSs) surrounding cerebral arteries, against
the direction of blood ﬂow3,4. Recent in vivo experiments in
rodents have shown the opposite: CSF enters the brain along
arterial PVSs, and this ﬂow plays a vital role in driving the
clearance of amyloid-β (Aβ) from the ISF at more downstream
locations1. In both cases, indirect experimental evidence suggests
that ﬂuid within PVSs is transported via bulk ﬂow5–7 and possibly
driven by arterial pulsations derived from the cardiac cycle8–11.
However, some have argued that PVS ﬂow is slow and has little
physiological importance, while others contest that physiologi-
cally relevant ﬂow occurs outside the PVS, within the basement
membrane of the vessels2,3,12. Moreover, several ﬂuid dynamical
modeling studies have questioned the feasibility of arterial
pulsation-driven ﬂow and have arrived at conﬂicting results in
terms of the magnitude and the overall direction of perivascular
CSF ﬂow13–15. Magnetic resonance imaging has made recent
strides in measuring diffusion coefﬁcients of the PVSs in rats and
has shown that the heartbeat dramatically increases the move-
ment of ﬂuid16. Nevertheless, this technique lacks sufﬁcient
temporal and spatial resolution to determine the velocity ﬁelds of
CSF in the PVS.
To evaluate ﬂuid motion within the PVS we have adapted
in vivo two-photon imaging to allow measurement of CSF ﬂow
speeds simultaneously with recordings of cardiac and respiratory
cycles. We have also performed synchronized measurements of
the artery diameter and heartbeat to determine vessel wall
dynamics. The analysis conﬁrms that CSF bulk ﬂow in the PVS is
pulsatile, at the same frequency as the cardiac cycle, and in the
same direction as blood ﬂow1,11. Our results are highly consistent
with a ﬂuid transport mechanism—perivascular pumping—
wherein vascular wall kinetics directly drive pulsatile CSF bulk
ﬂow in the PVS8. Furthermore, our in vivo measurements reveal
large PVSs surrounding pial arteries, with a cross-sectional area
larger than that of the artery, but perfusion ﬁxation collapses
these spaces to a tenth of their size in living animals. This ﬁnding
has signiﬁcant implications for future experimental and numer-
ical studies and highlights the importance of in vivo measure-
ment. Finally, we show that high blood pressure, a condition that
affects close to half of the world’s adult population, disrupts the
perivascular pump and sharply slows CSF transport in the PVS17.
Earlier studies have shown that arterial hypertension promotes
the accumulation and aggregation of Aβ18–21. We speculate that
hypertension-induced reduction of PVS ﬂuid transport con-
tributes directly to the associations between arterial hypertension
and Alzheimer’s disease.
Results
Quantifying ﬂow in perivascular spaces. CSF ﬂow was visualized
by infusing ﬂuorescent microspheres into the cisterna magna and
acquiring images through a sealed cranial window using two-
photon microscopy. Microspheres appeared in the PVSs of the
cortical branches of the middle cerebral artery (MCA) an average
of 292 ± 26 s after the infusion began; these PVSs are known to be
primary inﬂux routes for CSF into the brain22–24. The infusion
did not modify CSF ﬂow speed, and all data sets were collected
after the infusion was completed (Supplementary Fig. 1). The-
motion of the microspheres between consecutive frames,
which closely matches the motion of the surrounding
ﬂuid, was measured by performing particle tracking velocimetry
(PTV; Fig. 1a)25,26. In experiments spanning tens of minutes, we
typically tracked more than 20,000 particles (Fig. 1b and Sup-
plementary Table 1). The time-averaged net ﬂow of CSF is in the
same direction as the blood ﬂow and varies in space (Fig. 1c). It is
fast near the centers of the PVS channels, but slow inside arterial
bifurcations and near channel walls (Fig. 1d). Interestingly,
bifurcations of leptomeningeal arteries are also common sites of
amyloid-β accumulation in Alzheimer’s disease27; slow ﬂow in
the bifurcations might allow that accumulation. Velocity proﬁles
are nearly parabolic (Fig. 1e), as expected for laminar channel
ﬂow, with zero velocity at the PVS walls, as required by the no-
slip boundary condition. Averaging over both space and time, we
ﬁnd the typical ﬂow speed to be 18.7 µm s−1, with variation
among animals likely due to small differences in their PVS geo-
metries (95% conﬁdence interval 9.4–28 µm s−1; Fig. 1f). Mea-
suring typical ﬂow speeds enabled the ﬁrst-ever calculations of
Reynolds and Péclet numbers in PVSs. The Reynolds number is
typically ~0.001 (Fig. 1g), implying that the ﬂow is strictly
laminar, with inertial forces much smaller than viscous forces.
The high Péclet number (~1000, Fig. 1h) demonstrates that
advection dominates diffusive transport in the PVS15.
Perivascular space size, shape, and change during ﬁxation. By
superimposing all particle tracks from each experiment (Fig. 1b),
we can estimate the extent of the PVSs: each is ~40 µm wide,
comparable to the adjacent artery. Volumetric images using a
dextran CSF tracer conﬁrmed this result (Fig. 2a), and orthogonal
projections showed two non-connecting PVSs, one on each side
of the artery, with tracer excluded from the outer vessel wall
(Fig. 2b, c). The PVS size and shape that we observe agree with
in vivo measurements published previously (Fig. 2d)29,28,30 and
do not depend on whether PVSs are imaged through a cranial
window or a thinned skull (Supplementary Fig. 2). Identifying the
speciﬁc structures that bound the observed PVSs is a worthy topic
for future study.
We did not observe tracers in the basement membranes of the
arteries in our in vivo experiments, though prior studies of ﬁxed
tissue have observed them there1,3,22,24. Thus, we asked whether
tracers enter the vessel wall during tissue processing. Perfusion
ﬁxation with 4% paraformaldehyde (PFA) caused abnormal
retrograde ﬂow and shrunk the PVS (Fig. 2e–h and Supplemen-
tary Movie 1), and also moved tracer from the perivascular space
into the vessel wall (Fig. 2i, j). In vivo imaging showed that the
cross-sectional area of the PVS is on average about 1.4 times that
of the artery, whereas ﬁxation reduced this ratio to 0.14 (Fig. 2k).
Flow pulsing with heartbeat and driven by artery walls. Both
the cardiac and the respiratory cycles have been suggested as CSF
ﬂow drivers7–11,28,29. To identify the mechanisms driving ﬂow in
the PVS, we performed two-photon imaging while recording
synchronized measurements of the electrocardiogram (ECG) and
the respiratory cycle (Supplementary Movie 2). After performing
PTV, we computed the spatial root-mean-square velocity (vrms) at
every instant of time. The frequency of the vrms peaks matches
that of the heartbeat (R wave), but not that of respiration
(Fig. 3a). Power spectra and spectrograms are nearly identical for
vrms and ECG, demonstrating that the temporal behavior of vrms
is very closely linked to the cardiac cycle (Supplementary Fig. 3).
Probability density functions of the delay times (Δt) between an
ECG/respiration peak and the next vrms peak (Fig. 3c, inset)
indicate that the peak in vrms consistently occurs soon after the
heartbeat, whereas a respiration peak has no effect (Fig. 3c). We
hypothesize that the delay between the ECG peak and the vrms
peak corresponds to the time required for the pulse wave gen-
erated by each ventricular contraction to reach the brain. The vrms
is modulated strongly over the cardiac cycle (~99%) but weakly
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over the respiratory cycle (~22%; Fig. 3b, Supplementary Fig. 4a).
The modulation depth of the respiratory cycle varies among mice,
reaching 45% in some cases (Supplementary Fig. 4b-d). By many
measures, the cardiac cycle correlates more closely with CSF ﬂow
than the respiratory cycle does and is therefore a more likely
driver.
One mechanism by which the cardiac cycle might drive CSF
ﬂow is through motion of the arterial wall. We measured the
diameter of the pial artery at a ﬁxed location using line scans,
while making simultaneous ECG measurements (Fig. 3d), and
then computed the normalized average change in artery diameter
over the cardiac cycle (Fig. 3e). This average waveform shows a
fast diameter increase during the systolic phase and a slow
diameter decrease during the diastolic phase. This waveform is
substantially different from the sinusoid assumed in most
modeling studies13,30,31. Computing the derivative of the wave-
form produces the lateral velocity of the arterial wall (Fig. 3f),
which has a maximum of 21.2 ± 3.7 µm s−1 that occurs 34.5 ±
7.4 ms after the ECG peak. The peak in wall velocity and the delay
time are consistent with the peak and delay of Δvrms, suggesting
that the local displacement of the arterial wall drives CSF ﬂow via
perivascular pumping.
Perivascular pumping might drive more distal ﬂow if the CSF it
pumps displaces CSF that is more distal, according to the
continuity equation of ﬂuid dynamics. To test this possibility, we
tracked particles at more distal locations, including some near
arterioles that penetrate into the brain. In those locations, we
observed CSF pulsing in synchrony with the heart, with mean
ﬂow toward more distal locations (Supplementary Fig. 5), again
suggesting that perivascular pumping is a primary driver. Those
observations are consistent with the hypothesis that CSF enters
the brain through PVSs around arteries, mixes with interstitial
ﬂuid to absorb waste, and leaves the brain through PVSs around
veins, presented in prior studies1,32,33. Our observation that
microspheres infused into the cisterna magna are drawn to PVSs
around arteries, and not veins, is also consistent with that
hypothesis. The likely reason that ﬂows inside arterial bifurca-
tions are often stagnant is that perivascular pumping generates
opposing pressure gradients that sum to approximately zero in
these regions. Small differences in perivascular pumping strength
between each daughter vessel may drive slow reverse ﬂow (toward
more proximal locations) locally in this region. We have observed
substantial reverse ﬂow in only one bifurcation region of one
experiment; in this case, the daughter branches had signiﬁcantly
different diameters, suggesting the difference in perivascular
pumping strength may have been considerable. Flow in the
bifurcation, typically slow and complicated, deserves further
study; still, ﬂow in PVSs overwhelmingly proceeds toward more
distal locations.
Inducing acute hypertension to alter wall motion and ﬂow.
Having determined that perivascular pumping is a principal
driver of CSF ﬂow in the PVS, we next investigated the effect of
altering vascular wall dynamics. The amplitude and speed of the
vessel wall motion depend on several factors, especially vessel wall
stiffness, which depends on local blood pressure: as pressure
builds, vascular tone increases, reducing the compliance of the
wall39. Therefore, hypertension offers a model for altering vessel
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Fig. 1 CSF in the perivascular space is transported via bulk ﬂow. CSF ﬂow was imaged in live mice through a cranial window using two-photon microscopy.
To visualize the CSF, ﬂuorescent microspheres were infused into the cisterna magna. a Images for particle tracking velocimetry were acquired at 30 Hz.
Blood vessels were labeled with an intravenous (i.v.) dextran, while microspheres appear green; (inset) the magenta arrows show the instantaneous
velocity of each microsphere. b Superimposed trajectories of tracked microspheres show that particles are transported primarily within large PVSs. Scale
bar: 40 µm. c The time-averaged velocity ﬁeld (green arrows) shows that net transport is in the same direction as the blood ﬂow. d The local time-averaged
ﬂow speed shows that the interior region of the arterial bifurcation is nearly stagnant. Scale bars: 40 µm. e Average ﬂow speed proﬁles plotted as a function
of distance from the arterial wall. Colored lines in d indicate the location of each proﬁle. fMean ﬂow speeds, g Reynolds, and h Péclet numbers for the time-
averaged ﬂow, mean ± SEM, n= 13 mice
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wall dynamics. To induce arterial hypertension, we screened
several hypertensive agents and selected an intravenous infusion
of angiotensin-II (Ang-II) due to its tight temporal control on
increasing mean arterial blood pressure (Fig. 4a, b). Infusion of
Ang-II did not change the average arterial diameter (Fig. 4c) or
disrupt the blood–brain barrier (BBB; Supplementary Fig. 6). We
recorded arterial line scans at proximal and distal locations
(Fig. 4d) and measured the average vessel wall motion and
velocity. Both the arterial waveform and the wall velocity changed
substantially at distal locations during hypertension (Fig. 4e–g).
These changes are most likely caused by the arteries becoming
stiffer, such that waves are damped less; this primarily affects
smaller, distal arteries that have thinner, less muscular walls and
are therefore too weak to maintain ﬂexibility while supporting
increased blood pressure.
To test whether these changes in the vessel wall dynamics affect
the efﬁciency of the perivascular pump, we imaged CSF ﬂow and
simultaneously recorded ECG, respiration, and arterial blood
pressure before, during, and after administering Ang-II (Supple-
mentary Movie 3). The average ﬂow speed (Fig. 5a) was reduced
by ~40% during Ang-II-induced hypertension (Fig. 5b). This
decrease in ﬂow speed was independent of the time after infusion
(Supplementary Fig. 7a-b). Also, microsphere trajectories show
more backﬂow during each cardiac period in acute hypertension
(Fig. 5a, insets). To quantify changes in the instantaneous ﬂow
rate, we computed the downstream component of every velocity
measurement (Fig. 5c, d). Hypertension increases backﬂow
(negative downstream velocity) by 21% relative to controls
(Fig. 5e and Supplementary Fig. 7c). A small percentage of the
microspheres aggregate and adhere to the PVS wall, remaining in
the imaging ﬁeld for the duration of the experiment; however,
hypertension did not increase the number of these stuck particles
compared to the controls (Supplementary Fig. 8).
Discussion
Our measurements provide the ﬁrst detailed evidence of peri-
vascular pumping in PVSs of the rodent brain (Supplementary
Movie 4). Although we cannot exclude the possibility that addi-
tional mechanisms may drive CSF through PVSs, we note that
any steady external pressure gradient (resulting from production
of CSF, for example) must typically be weaker than perivascular
pumping, since the resulting ﬂow often reverses direction during
each cardiac cycle.
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Fig. 2 Perivascular spaces (PVSs) are larger in vivo and collapse after ﬁxation. a Fluorescent dextran in the CSF conﬁrms the size of the PVS in vivo.
b Cross-section at the dashed line in a, showing two PVSs with tracer. c Cross-sections proximal, across, and distal to a bifurcation show that the non-
connecting PVS structure continues. d Average measurements of the width of the PVS from superimposed microsphere trajectories (e.g., Fig. 1b). Mean ±
SEM, n= 13 mice. e To test whether the PVS and CSF tracer distribution were modiﬁed during tissue processing, we perfusion ﬁxed a live anesthetized
mouse with f phosphate-buffered saline (PBS) followed by g 4% paraformaldehyde (PFA) to h ﬁx the tissue (Supplementary Movie 1). Diagrams are
included below each image indicating our observations. Scale bar: 30 µm. i The vasculature was labeled with a lectin in the PBS perfusion solution and the
same vessel in the same animal shown in a was imaged after ﬁxation. It was necessary to remove dura to image the same vessels in situ due to the
shrinkage of the brain. Small arrows point to a fold in the collapsed artery wall and tracer being redistributed around a pial vein. Overlapping lectin and
dextran appear yellow. Scale bar: 40 µm. j Cross-section at the dashed line in i shows that after ﬁxation, the vessel collapses and folds, and the tracer
redistributes around the arterial wall. Scale bar: 20 µm. k To quantify the size of the PVS compared to that of the artery, we computed the ratios of the
areas of the PVS and the adjacent artery for in vivo measurements utilizing tracked microspheres and dextran dye and after ﬁxation (ﬁxed). The lateral area
of the PVS is roughly 1.4 ± 0.1 times larger than that of the artery itself in the live mice, and ﬁxation reduces this ratio to about 0.14 ± 0.04. One-way
analysis of variance (ANOVA) post hoc Tukey's test, ***P < 0.0002, ns not signiﬁcant, mean ± SEM, n= 6–7/group
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Our observations of PVSs collapsing during perfusion ﬁxation
may explain prior discrepancies in PVS size estimates, and have
implications for future experimental studies. During collapse, the
PVS cross-sectional area decreases by a factor of 10; CSF ﬂows
vigorously toward the cisterna magna, in the opposite direction
observed in live animals; and ﬂuorescent tracers move from the
PVS to the basal lamina between the vascular smooth muscle
cells. Thus, future experimental studies should be mindful of the
facts that the PVS changes dramatically during ﬁxation and that
the distribution of CSF tracers in histological sections does not
reﬂect their locations when the animals were alive. The PVS sizes
we observe have implications for future modeling studies, since
width is a sensitive parameter in ﬂuid dynamical models;
hydraulic ﬂow resistance scales with the inverse fourth power of
the width. The exact path by which CSF ﬂows into the brain is an
important topic of future research; its study will require new
methods because particles large enough to be tracked individually
are not transported along the PVSs of penetrating arterioles, as
demonstrated by our experiments and prior studies11.
We ﬁnd that the perivascular pump becomes less efﬁcient in
acute arterial hypertension due to increased backﬂow, likely
arising from changes in the vessel wall dynamics. In particular,
acute arterial hypertension leads to a change in the waveform of
the arterial wall motion and a greater negative wall velocity,
which may explain the increase in backﬂow. Furthermore, these
blood pressure-dependent changes in waveform and wall velocity
are larger at more distal locations, which is a common feature of
arterial hypertension34. Since CSF ﬂow drives waste clearance in
the brain, and prior studies in both rodents and humans have
demonstrated that hypertension is correlated with amyloid-β
accumulation18–21, our study offers evidence for a novel causal
mechanism: arterial hypertension induces a change in vessel
dynamics that reduces perivascular pumping, decreasing the net
ﬂow of CSF in PVSs. Conservation of mass dictates that such a
decrease in the PVS ﬂow will lead to a similar decrease
throughout the glymphatic system, a brain clearance pathway
shown to play a role in amyloid-β removal1. Hence hypertension,
a known risk factor for Alzheimer’s disease, may reduce par-
enchymal waste transport. The decrease in CSF ﬂow that we
observe in acute arterial hypertension could be explained by
stiffening of artery walls, which suggests that the same mechan-
ism may be relevant for chronic hypertension and arteriosclerosis.
Future studies, using methods that better model human essential
hypertension (spontaneous hypertensive mice or slow pressor
angiotensin-II infusion), will provide insight into how vascular
remodeling in response to long-lasting elevation of blood pressure
affects PVS ﬂuid transport.
Methods
Animals and surgical preparation. All experiments were approved by the Uni-
versity Committee on Animal Resources of the University of Rochester Medical
Center (Protocol No. 2011-023) and an effort was made to minimize the number of
animals used. Male C57BL/6 mice, 8–12 weeks of age (Charles River), were
anesthetized with ketamine/xylazine (100/10 mg kg−1, intraperitoneally). Body
temperature was maintained at 37.5 °C with a rectal probe-controlled heated
platform (Harvard Apparatus). A cranial window was prepared over the MCA
vascular territory on the right anterolateral parietal bone leaving dura mater intact.
The cranial window was sealed with agarose (0.8% at 37 °C) and a glass coverslip to
prevent intracranial depressurization35. For a subset of experiments, instead of a
cranial window, mice received a thin-skull preparation9,36. Afterwards, a cannula
was placed in the cisterna magna and red ﬂuorescent polystyrene microspheres
(FluoSpheres™ 1.0 µm, 580/605 nm, 0.25% solids in artiﬁcial CSF (aCSF), Invitro-
gen) were brieﬂy sonicated and infused at 2 µl min−1 for 5 min1.
Measurement of vital signs. ECG and respiratory rate were acquired at 1 kHz and
250 Hz, respectively, using a small animal physiological monitoring device (Har-
vard Apparatus). Arterial blood pressure was measured through an arterial catheter
placed in the femoral artery and connected to a pressure transducer and monitor
(World Precision Instruments). The signals were digitized and recorded with a
DigiData 1550A digitizer and AxoScope software (Axon Instruments).
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Acute arterial hypertension induction. Angiotensin-II (Tocris) was dissolved in
NaCl 0.9% and infused into a femoral vein catheter at 5 ng g−1 min−1 at a volu-
metric rate of 1 µl min−1 using a syringe pump (Harvard Apparatus) for the
duration of the experiment. Mice with less than a 20 mmHg increase in blood
pressure were excluded from the analysis. Control mice received an intravenous
infusion of NaCl 0.9% at 1 µl min−1.
In vivo two-photon laser scanning microscopy. Two-photon imaging was per-
formed using a resonant scanner B scope (Thorlabs) with a Mai Tai DeepSee HP
Ti:Sapphire laser (Spectra Physics) or a Chameleon Ultra II laser (Coherent)
attached to a galvo confocal scanning system (Fluoview 300, Olympus). A water-
immersion 20× objective (1.0 NA, Olympus) was used on both systems. Intra-
vascular ﬂuorescein isothiocyanate–dextran (FITC–dextran, 2,000 kDa) and red
microspheres were excited at an 820 nm wavelength. Images were acquired at
30 Hz (ThorSync software) simultaneously with physiological recordings (3 kHz,
ThorSync software). Prior to infusion of the microspheres, a volumetric image of
the vascular topology was acquired. Segments of the MCA were identiﬁed as large
caliber surface vessels (50–60 µm diameter) that started at the anterolateral aspect
of the window and traveled towards the midline. Direction of blood ﬂow was
conﬁrmed before and after imaging using line scans.
Correlative imaging. To conﬁrm the size of the PVS, a separate group of anes-
thetized mice received an intracisternal injection of Texas-Red dextran (2000 kDa,
0.5% in aCSF, Invitrogen) instead of microspheres. The dextran tracer was deliv-
ered using the same infusion paradigm as described above. After tracer reached the
PVS of the cortical arteries, volumetric images were acquired for cross-sectional
reconstruction. Mice were then perfused with a phosphate-buffered saline (PBS)
solution with an Alexa Fluor 488 wheat germ agglutinin lectin (15 µg ml−1, Invi-
trogen) through an arterial catheter. Afterwards, mice were perfusion-ﬁxed with
4% PFA. After ﬁxation, the coverslip and the dura mater were removed due to
tissue shrinking and images were acquired as described above.
BBB permeability assay. FITC-conjugated dextran (1%; 70 kDa; Sigma-Aldrich)
in normal saline (4 ml kg−1) was injected via a femoral vein catheter. The dextran
was allowed to circulate for 30 min while mice received either an Ang-II or NaCl
0.9% infusion (1 µl min−1). The brains were harvested, sectioned, and FITC
extravasation was imaged and quantiﬁed (see below).
Tissue processing and imaging. For assessment of BBB permeability, mice were
transcardially perfused with ice-cold 0.1 M PBS (pH 7.4, Sigma-Aldrich) followed
by 4% PFA. Brain tissue was carefully dissected away from the skull and dura then
post-ﬁxed overnight in 4% PFA at 4 °C. For correlative imaging, mice were per-
fusion ﬁxed as before but Alexa 488-conjugated lectin from wheat germ agglutinin
(15 µg ml−1; Invitrogen) was added into the ice-cold PBS solution prior to the PFA
perfusion step.
Ex vivo ﬂuorescence imaging. Coronal slices (100 µm thickness) were obtained
using a calibrated vibratome (VT1200S, Leica). Beginning at the anterior aspect of
the corpus callosum, one section was collected every 5 sections until a total of
6 sections had been acquired for each animal. Brain sections were mounted with
ProLong Gold Antifade with 4′,6-diamidino-2-phenylindole (DAPI; Invitrogen).
Coronal sections were imaged at ×4 magniﬁcation using a montage epiﬂuorescence
microscope (BX51 Olympus and CellSens Software). Exposure times and magni-
ﬁcations were kept the same for all groups.
Image processing. The images obtained from two-photon microscopy are 16-bit
with two channels (red and green), each with spatial dimensions of 512 × 512. The
green channel captures the FITC–dextran in the vasculature, while the red channel
captures the ﬂuorescent microspheres ﬂowing in the perivascular spaces. Note that
in the ﬁgures presented in this study, we have interchanged the two channels to
improve clarity (red vasculature is more intuitive), but the discussion here will refer
to the two channels by their accurate, pre-interchanged colors. The ﬁrst step of
image processing is to perform image registration. A time series of rigid transla-
tions (no rotation or deformation) is calculated to an accuracy of 0.2 pixel using an
efﬁcient algorithm in MATLAB37. The translations are inspected for outliers
(where the algorithm has failed due to an erroneous correlation) which are
manually corrected via linear interpolation. Images from both the red and green
channels are then sequentially read and rewritten with the rigid translations
applied; the edges of each image are padded with zero-valued pixels such that all
ﬁnal images in each time series have the same spatial dimensions. One mouse was
excluded because image registration could not be performed effectively. The second
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and ﬁnal step of image processing was to mask regions with stagnant microspheres
in the red channel. This was achieved by computing the average of the entire time
series of registered red channel images, then applying a threshold to generate a
binary mask. The binary mask was used as input to the particle tracking veloci-
metry software (discussed below) such that regions above the threshold were
completely masked from any velocity measurements. This masking technique
ensured that stagnant particles (typically stuck to the boundaries of the perivascular
space) did not erroneously decrease the measurements of the ﬂow speed. BBB
permeability to FITC–dextran was quantiﬁed from ex vivo coronal sections by a
blinded investigator. Each slice was analyzed for mean pixel intensity and the
average was computed for all 6 sections taken from one brain. Full width at half
maximum was quantiﬁed by measuring the intensity distribution across the center of
20 randomly selected particles from both types of cranial windows. All images were
analyzed using ImageJ software (National Institutes of Health, imagej.nih.gov/ij/).
Particle tracking velocimetry. To obtain measurements of the speed of cere-
brospinal ﬂuid ﬂow, we have quantiﬁed the motion of the microspheres in each
registered time series of images using an automated PTV software in
MATLAB25,26. This algorithm individually locates each particle with subpixel
accuracy, tracks its location throughout the time series of images, and calculates its
velocity in each frame. Hence, for each particle, a time series of positions and
velocities is obtained. To further ensure that no stagnant particles were included in
our measurements, we computed the average speed along each particle track by
dividing the total displacement by the total number of frames in which that particle
was tracked; particle tracks with average speeds lower than a given threshold
(typically about 2 µm s−1) were excluded from the analysis. Supplementary Table 1
shows the total number of particle tracks and the total number of velocity mea-
surements obtained for each of the 13 mice for which PTV has been performed. To
compute the time-averaged ﬂow velocity and speed, the domain was divided into
approximately 70 × 70 boxes of resolution 7.5 × 7.5 pixels each. All individual
velocity measurements for a given time interval were then binned and averaged
according to their box positions. Average ﬂow speeds were computed using only
bins which had sufﬁcient measurements (at least 20). Stagnant or nearly stagnant
regions were excluded when calculating the changes in ﬂow speed. Mice with fewer
than 80 non-stagnant bins with sufﬁcient measurements were excluded from the
analysis. To calculate vrms, we computed the spatial root-mean-square of all speed
measurements obtained at each instant of time.
Calculation of Reynolds and Péclet numbers. The Reynolds number is calculated
as:
Re ¼ UL
ν
; ð1Þ
where U is the spatial mean of the magnitude of the time-averaged ﬂow velocity
(e.g., the mean of measurements shown in Fig. 1d), L= 4.4 × 10−5 m is the average
PVS width that has been measured (Fig. 2d), and ν= 0.697 × 10−6 m2 s−1 is the
kinematic viscosity of water at 36.8 °C (a good approximation for cerebrospinal
ﬂuid). The Péclet number is calculated as:
Pe ¼ UL
D
; ð2Þ
where D= 6.55 × 10−13 m2 s−1 is the diffusion coefﬁcient for 1 µm spherical par-
ticles in a liquid at low Reynolds number. The diffusion coefﬁcient is calculated
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using the Stokes–Einstein equation:
D ¼ kT
6πηr
; ð3Þ
where k= 1.38 × 10−23 m2 kg s−2 K−1, T= 310 K is the body temperature of a
mouse, η= 6.93 × 10−4 kg m−1 s−1 is the dynamic viscosity of water at 36.8 °C, and
r= 0.5 × 10−6 m is the microsphere radius.
Artery diameter and wall velocity measurements. All line scans were recorded
transverse to the MCA. The line scans were recorded at about 600 Hz with syn-
chronized ECG measurements, from which we obtained about 120 artery diameter
measurements per cardiac cycle (depending on the heart rate). Line scans at each
location were recorded for at least 45 s. For each line scan time series, the outer
edges of the artery were located with subpixel accuracy at each instant of time by
performing a cubic interpolation of the pixel intensity proﬁle onto a ﬁner grid and
identifying the two locations where the pixel intensity crossed a given threshold.
For each time series, the threshold value was chosen to approximately coincide
with the region of the steepest gradient in the pixel intensity proﬁle. The artery
diameter at each instant of time was calculated by measuring the distance between
these two locations. Using the synchronized ECG measurements, the cardiac cycle
was deﬁned by sequential peaks of the R wave. The change in artery diameter was
then calculated as the difference between the instantaneous artery diameter and a
two-cardiac-cycle moving average of the artery diameter. The changes in artery
diameter measurements were then binned and averaged according to the fraction
of the cardiac cycle to obtain the mean change in the artery diameter Δd; this
quantity was then normalized by dividing by the average artery diameter d. To
measure the artery wall velocity, the mean change in artery diameter measurements
(in dimensional distance versus time units) for each animal was ﬁt with a high-
order Fourier series in MATLAB and the derivative was calculated analytically.
Downstream velocity component. The downstream velocity component is cal-
culated as u  buavg , where u is the instantaneous particle velocity and buavg is a ﬁeld
of unit vectors computed from the time-averaged velocity ﬁeld (see, e.g., Fig. 1c).
PVS/artery area ratio. Each area used in computing an area ratio was obtained in
MATLAB by generating a binary image of the relevant space (perivascular space or
artery) and summing the binary image. To generate a binary image for a region
which was visualized via ﬂuorescent dye, a carefully chosen threshold was applied
to each given image. To generate a binary image indicating the area of the peri-
vascular spaces using microsphere trajectories, we followed the following proce-
dure: all microsphere locations over the entire time series were superimposed onto
one large set of coordinates. These (subpixel) coordinates were then rounded to the
nearest pixel, and each microsphere was inﬂated to encompass a 3 × 3 pixel region.
This set of coordinates was then used to construct the binary image. Before the area
ratio was computed, a region of interest was manually chosen for the calculation
such that we excluded the vasculature and perivascular spaces not associated with
the middle cerebral artery. Furthermore, any region of overlap between the two
binary images was subtracted from the perivascular binary image so that the area
ratio would characterize the lateral extent of the perivascular space beyond the
artery. Three-dimensional surface reconstructions and orthogonal views of the PVS
were done using Imaris (Bitplane).
Statistical analysis. All statistical analyses were performed on GraphPad Prism 7
(GraphPad Software). No sample size calculations were done due to the lack of an
existing effect size estimate. An effort was made to have n > 5 for each experiment.
Statistical tests were selected after evaluating normality (D’Agostino–Pearson
omnibus test) or after visualization of the distribution of data when the sample size
did not allow for testing. In the latter cases, both parametric and nonparametric
tests were performed and, in all cases, yielded the same result. All testing was two-
tailed and exact P values were calculated at a 0.05 level of signiﬁcance and stated in
the ﬁgure legends. Animals were not randomized and blinding was done where
possible, but was generally not practical for PTV given that the investigator
required access to the arterial blood pressure data for analysis.
Code availability. All relevant codes are available from the authors.
Data availability
All relevant data are available from the authors. A reporting summary for this
article is available as a Supplementary Information ﬁle.
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